Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
2HQ:SWSIX Swiss Ex

Tilray Inc

COMPANY INFO
46.18CHF
Market Closed
As of 10/16/2019 EDT
Open
--
Prev Close
46.18
Volume
0
Market Cap
2.143B
52 Week Range
34.82155.29
1D1M1Y5Y
View Full Chart
No pricing data is available for this time frame
Market Closed
As of 10/16/2019 EDT
1D1M1Y5Y
View Full Chart
No pricing data is available for this time frame
markets
Brexit, China Trade Offer Positive Direction for Markets: AllianzGI
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
PEGY Ratio--
Shares Outstanding80.98M
Price to Book Ratio6.0064
Price to Sales Ratio22.4562
1 Year Return-69.39%
30 Day Avg Volume--
EPS--
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending Q3/2019:11/26/2019

About Tilray Inc

Tilray, Inc. operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.
Address
1100 Maughan Road Nanaimo, BC V9X 1J2 Canada
Phone
1-844-845-7291
Website
store.tilray.ca

Income Statement

Quarterly
Annual
;
Q2 2019 (Millions USD)
  • Revenue
    45.90
  • Net Income
    -35.05
  • Profit Margin
    -76.36%

Balance Sheet

Quarterly
Annual
;
Q2 2019 (Millions USD)
  • Total Assets
    1,024.13
  • Total Liabilities
    663.96
  • Debt to Assets
    42.44%

Cash Flow

Quarterly
Annual
Q2 2019 (Millions USD)
  • Operating
    -85.39
  • Investing
    -29.08
  • Financing
    4.81